Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin heavy variable 1-45 (IGHV1-45) is a gene segment encoding one of the variable (V) domains for the heavy chain of immunoglobulins, also known as antibodies[1][5]. The V region is critical for the recognition and binding of specific antigens, forming a part of the antigen binding site together with variable regions of light chains[1][3][5]. IGHV1-45 itself is not a complete protein or receptor but is used in the assembly of antibody variable domains through a process of somatic recombination (V-(D)-J recombination) during B cell development, resulting in the vast diversity of antibody specificities in the adaptive immune system[1][3]. The genes of the IGHV family, including IGHV1-45, are located in the immunoglobulin heavy chain (IGH) locus on chromosome 14[5][6]. They show significant allelic diversity, contributing to variations in immune response between individuals and populations[2][6]. While IGHV rearrangements and mutational status have clinical significance as biomarkers in certain B cell malignancies, IGHV1-45 is not a therapeutic target like a receptor, enzyme, or transporter; rather, it encodes part of the antibody variable region essential for antigen recognition[1][3][5]. No drugs act directly on IGHV1-45 itself, although the gene's characteristics may influence disease development or disease monitoring in hematologic malignancies[4][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin heavy variable 1-45 (IGHV1-45).